Clinical Research Directory
Browse clinical research sites, groups, and studies.
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
Sponsor: University of Alabama at Birmingham
Summary
This Phase II, parallel-group, masked, randomized clinical trial aims to evaluate whether a DHA/ARA-enriched, fortified human milk diet administered during the first 14 days of life reduces respiratory morbidity and improves lung function in extremely preterm (EPT) infants (born at ≤28 weeks gestation).
Official title: Improving Lung Health in Premature Babies Through Early Nutrition: The More & Early Nutritional Delivery for Bronchopulmonary Dysplasia (MEND-BPD) Trial
Key Details
Gender
All
Age Range
1 Day - 3 Days
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2026-05-31
Completion Date
2029-07-31
Last Updated
2025-12-29
Healthy Volunteers
No
Interventions
High-energy group
Study participants assigned to the intervention group will receive a standard, fortified human milk diet plus a DHA/ARA supplement during the first 2 weeks after birth.
Standard-energy group
Study participants assigned to the intervention group will receive a standard, fortified human milk diet during the first 2 weeks after birth.
Locations (1)
University of Alabama at Birmingham
Birmingham, Alabama, United States